
Key points
- A correctly placed Essure microinsert appears on CT as a curvilinear metallic density spanning the uterotubal junction at the uterine cornua; the normal fallopian tube course is not delineated on CT, so the device may appear to extend beyond the uterine contour.
- A short curvilinear metallic foreign body in the peritoneal cavity means the insert has extruded, from tubal perforation at the time of placement or distal migration through the tube – a rare complication, reported in about 0.04% of placements.
- Overly distal placement increases the risk of tubal perforation and peritoneal extrusion, and left-sided inserts are more often reported to migrate than right-sided ones.
- Extruded devices cause chronic pelvic pain and can induce peritoneal adhesions with potential small bowel obstruction, so they require surgical removal; CT is the adjunct used to locate the device or fragments before laparoscopic retrieval.
- HSG is the test of choice for confirming device position and tubal occlusion; on ultrasound the insert is an echogenic linear structure with myometrium surrounding it, and on MRI it produces susceptibility artifact at the cornua.
- Essure sales stopped in 2017 and US use ended in 2018, but many women still carry the inserts – assess device position whenever it is seen incidentally on CT, ultrasound, MRI or PET-CT.
